Skip to main content
. 2015 Nov 30;2015:204893. doi: 10.1155/2015/204893

Table 1.

Comparison of clinical characteristics between DN groups.

Total (n = 421) Patients without DN (n = 218) Patients with DN (n = 203) P
Age (y) 61.06 ± 10.35 59.59 ± 10.03 62.64 ± 10.48 <0.01
Gender (male/female) 213/208 115/103 98/105 0.36
Diabetic duration (years) 9.67 ± 7.45 8.57 ± 7.52 10.85 ± 7.21 <0.01
Smoking habit, n (%) 142 (33.7) 83 (38.1) 59 (29.1) 0.06
BMI (kg/m2) 24.92 ± 3.23 24.50 ± 2.99 25.37 ± 3.41 <0.01
Hypertension, n (%) 244 (58.0) 100 (45.9) 144 (70.9) <0.01
SBP (mmHg) 133.03 ± 15.86 129.99 ± 15.49 136.29 ± 15.61 <0.01
DBP (mmHg) 79.66 ± 9.10 77.84 ± 8.97 81.67 ± 8.84 <0.01
FPG (mmol/L) 8.50 ± 2.73 8.15 ± 2.56 8.88 ± 2.86 <0.01
HbA1c (%) 8.8 (7.4–10.3) 8.7 (7.3–10.3) 8.9 (7.5–10.1) 0.70
SCr (μmol/L) 60.0 (48.5–72.0) 57.0 (48.0–68.0) 63.0 (50.0–77.0) <0.01
TG (mmol/L) 1.55 (1.13–2.32) 1.41 (1.04–2.02) 1.81 (1.25–2.76) <0.01
TC (mmol/L) 4.92 ± 1.00 4.85 ± 0.92 5.00 ± 1.08 <0.01
HDL-C (mmol/L) 1.10 ± 0.24 1.13 ± 0.24 1.07 ± 0.24 <0.01
LDL-C (mmol/L) 2.86 ± 0.80 2.83 ± 0.77 2.89 ± 0.84 0.46
UACR (mg/g) 29.0 (16.0–75.0) 16.0 (11.0–23.0) 80.0 (48.0–154.0) <0.01
eGFR (mL/min·1.73 m2) 115.40 ± 35.86 125.20 ± 33.25 104.79 ± 35.63 <0.01
Insulin, n (%) 133 (31.6) 57 (26.1) 76 (37.4) 0.01
ACEI/ARB, n (%) 83 (19.7) 28 (12.8) 55 (27.1) <0.01
Statins/fibrates, n (%) 104 (24.7) 38 (17.4) 66 (32.5) <0.01
DR, n (%) 126 (29.9) 47 (21.6) 79 (38.9) <0.01
TSH (mIU/L) 1.96 (1.38–2.74) 1.87 (1.35–2.73) 2.14 (1.40–2.74) 0.10
FT3 (pmol/L) 3.88 ± 0.42 3.95 ± 0.41 3.81 ± 0.42 <0.01
FT4 (pmol/L) 16.88 ± 2.34 16.96 ± 2.41 16.81 ± 2.25 0.52

Data are expressed as means ± SD, median (interquartile range), or numbers (percentages).

DN, diabetic nephropathy; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; SCr, serum creatinine; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UACR, urinary albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; DR, diabetic retinopathy; TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, free thyroxine.